Which hedge funds own MNPR? MONOPAR THERAPEUTICS INC, Q2 2026 13F holders
27 tracked hedge funds disclosed a position in MNPR (MONOPAR THERAPEUTICS INC) in their Q2 2026 13F filings, worth $258.9m in total. The largest holder by portfolio weight is Saturn V Capital Management LP at 4.1% of its book. 12 opened a new position this quarter: Ishara Investments LP, Ikarian Capital, LLC, Stempoint Capital LP, Orbimed Advisors LLC. 4 exited: Sio Capital Management, LLC, Silverarc Capital Management, LLC, Walleye Capital LLC.
- 27
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 12
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 4
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $40.3m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $16.5m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $259m
- Combined value Sum of the holders' reported positions in the security.
- 2.2%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Sio Capital Management, LLC | 1.4% | $9.5m |
| Silverarc Capital Management, LLC | 0.3% | $2.4m |
| Walleye Capital LLC | 0.02% | $3.5m |
| Squarepoint Ops LLC | 0.0% | $1.2m |
Ownership over time
Who discovered MNPR first? Beta
The run: Q4 2023 → Q2 2026, ×54
| ADAR1 Capital Management, LLC | Q4 2024 | – | +1.3 pts |
| Ally Bridge Group (NY) LLC | Q3 2025 | – | +1.3 pts |
| Saturn V Capital Management LP | Q3 2025 | – | +1.2 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.